Welcome to the CCLS one-day conference!
All you need to know about the CCLS NZ 2025 conference and workshop in Christchurch on 14-15 March
Adele Jefferies3 min read
Ophthalmology News
What DOES glaucoma look like?
Shining a spotlight on glaucoma this month, Glaucoma New Zealand (GNZ) is sharing patient stories explaining their experiences of the disease and is inviting the country’s optometrists and ophthalmologists to help them share the message and keep referring patients.
Staff reporters2 min read
Alcon acquires Cylite
Alcon has acquired Melbourne-based Cylite, known for its hyperparallel optical coherence tomography (HP-OCT) technology. “We are excited about the potential of this technology in whole-eye OCT imagi
Staff reporters2 min read
Weight-loss drugs implicated in vision loss
US researchers have found a possible link between weight-loss drugs and ophthalmic complications
Staff reporters1 min read
Glaukos makes MIGS and CXL inroads
Glaukos has announced positive clinical updates for its iDose sustained release procedural pharmaceutical platform. The tech company’s 36-month follow-up analysis of its two phase 3 iDoseTR (travopr
Staff reporters2 min read
Commerce Commission censures RANZCO
NZ’s Commerce Commission responds after investigating RANZCO letter re: training optoms to provide laser treatments
Drew Jones3 min read
Retinal imaging reveals Covid impact
Retinal imaging could help doctors diagnose and track how ‘long-Covid’ impacts people over time and provide insight into its causes, according to the authors of US study. Researchers used advan
Staff reporters2 min read
Game-changing donation to fight glaucoma
The largest, single philanthropic investment in vision science in Australia to prevent blindness from glaucoma brings hope to millions.
Staff reporters2 min read
ARPA-H supports whole eye transplant
A US health agency is committing up to NZ$217.41m to develop the first-ever vision-restoring eye transplant.
Staff reporters2 min read
Essilor expands med-tech portfolio
EssilorLuxottica has signed an agreement to acquire Espansione Group, the Italian manufacturer of Meibomask, a low-level light therapy (LLLT) device, and OPE (optimal power energy) intense pulsed light device, for patients with meibomian gland dysfunction, blepharitis or Sjögren syndrome and other c
Staff reporters1 min read
Cutting-edge CL gel delivers medication
Chemistry researchers at Canada’s University of Waterloo have developed a 3D-printed hydrogel for continuous drug delivery via contact lenses (CLs).
Staff reporters2 min read
Dual-action MIGS reaches NZ
Medix21 is bringing New World Medical’s Streamline Surgical System, a novel dual-action device to manage intraocular hypertension and the progression of open angle glaucoma, to New Zealand.
Staff reporters2 min read